Simulations Plus Stock News

Simulations Plus' (SLP) fiscal second-quarter results benefit from strong performance of the company's higher-margin software business.

Simulations Plus, Inc.'s (SLP) CEO Shawn O'Connor on Q2 2021 Results - Earnings Call Transcript

Simulations Plus (SLP) delivered earnings and revenue surprises of 7.14% and 1.68%, respectively, for the quarter ended February 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of Simulations Plus (NASDAQ:SLP) moved higher after the company reported Q2 results. Quarterly Results Earnings per share increased 25.00% over the past year to $0.15, which beat the estimate o

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today reported record 2nd quarter results for FY2021. Net revenue of $13.1 million, up 27% over 2QFY20; YTD revenue of $23.8 million.

On Monday, April 12, Simulations Plus (NASDAQ:SLP) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Simulations Plus (SLP) fiscal second-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech industri

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus reports excellent results from its Artificial Intelligence-driven Drug Design (AIDD) module in ADMET Predictor in testing by partner.

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced that its DILIsym division and the University of Pittsburgh Drug Discovery Institute jointly received a Phase I SBIR grant.

What's better than rapid growth and a dividend payment?

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus will host fireside chat at BTIG's Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Feb. 18, at 12pm ET.

The modelling and simulation software market for drug discovery and development is niche and IP-intensive, with high barriers to entry. Simulations Plus has a good track record and strong balance shee

Simulations Plus (SLP) fiscal first-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.

The company continues to anticipate swift, double-digit revenue growth over the next several quarters.

New York, New York--(Newsfile Corp. - January 12, 2021) -  Levi & Korsinsky announces it has commenced an investigation of Simulations Plus, Inc. (NASDAQ: SLP) concerning possible breaches of fiducia